Lipoplus 20%

Saturated fatUnsaturated fatMonounsaturated fatPolyunsaturated fat Monounsaturated fatPolyunsaturated fat Fatty acid(Essential fatty acid)Omega−3Omega−6Omega−7Omega−9TriglycerideCholesterol Omega−3Omega−6Omega−7Omega−9 Fat hydrogenationTrans fatFat interesterification Trans fat vte Omega−3 fatty acids, also calledomega−3 oils,ω−3 fatty acidsorn−3 fatty acids,arepolyunsaturated fatty acids(PUFAs) characterized by the presence of adouble bondthree atoms away from the terminalmethyl group(numberedω, the last letter of theGreek alphabet) in their chemical structure.They are widely distributed in nature, are important constituents of animallipid metabolism, and play an important role in the human diet and in human physiology.The three types of omega−3 fatty acids involved in human physiology areα-linolenic acid(ALA),eicosapentaenoic acid(EPA) anddocosahexaenoic acid(DHA). ALA is found in some land plants, while DHA and EPA are found in algae and fish.Marine algaeandphytoplanktonare primary sources of omega−3 fatty acids.DHA and EPA accumulate in fish that eat these algae.Common sources of land plants containing ALA includewalnuts,chia seeds, andflaxseedsas well ashempseed oil, while sources of EPA and DHA include fish andfish oils,andalgae oil. Almost without exception, animals are unable to synthesize theessentialomega−3 fatty acid ALA and can only obtain it through diet. However, they can use ALA, when available, to form EPA and DHA, by creating additional double bonds along its carbon chain (desaturation) and extending it (elongation). ALA (18 carbons and 3 double bonds) is used to make EPA (20 carbons and 5 double bonds), which is then used to make DHA (22 carbons and 6 double bonds).The ability to make the longer-chain omega−3 fatty acids from ALA may be impaired in aging.In foods exposed to air, unsaturated fatty acids are vulnerable tooxidationandrancidity. Omega−3 fatty acid supplementation has limited evidence of benefit in preventingcancer, all-cause mortality and mostcardiovascularoutcomes, although it modestlylowers blood pressureand reducestriglycerides. Since 2002, the United StatesFood and Drug Administration(FDA) has approved four fish oil-based prescription drugs for the management ofhypertriglyceridemia, namely Lovaza, Omtryg (bothomega-3-acid ethyl esters), Vascepa (ethyl eicosapentaenoic acid) and Epanova (omega-3-carboxylic acids).